Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside

Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside

Oxidative stress and chronic inflammation have been implicated in the pathophysiology of metabolic diseases, including diabetes mellitus (DM), metabolic syndrome (MS), fatty liver (FL), atherosclerosis (AS), and obesity. Molecular hydrogen (H<sub>2</sub>) has long been considered a physi...

Full description

Bibliographic Details
Main Authors: Fei Xie, Yifei Song, Yang Yi, Xue Jiang, Shiwen Ma, Chen Ma, Junyu Li, Ziyi Zhanghuang, Mengyu Liu, Pengxiang Zhao, Xuemei Ma
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceuticals
Subjects:
molecular hydrogen (H<sub>2</sub>)
metabolic diseases
oxidative stress
pre-clinical studies
clinical trials
Online Access:https://www.mdpi.com/1424-8247/16/4/541

Internet

https://www.mdpi.com/1424-8247/16/4/541

Similar Items